Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same

Details for Australian Patent Application No. 2003213142 (hide)

Owner Schering Corporation

Inventors Ugwu, Sydney; Witchey-Lakshmanan, Leonore C; Ihnat, Peter M; Radhakrishnan, Vinay

Agent Griffith Hack

Pub. Number AU-B-2003213142

PCT Number PCT/US03/05018

PCT Pub. Number WO2003/072082

Priority 60/359,198 22.02.02 US

Filing date 20 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 10 November 2005

International Classifications

A61K 009/08 Medicinal preparations characterised by special physical form - Solutions

A61K 047/18 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Event Publications

24 July 2003 Complete Application Filed

  Priority application(s): 60/359,198 22.02.02 US

16 October 2003 Application Open to Public Inspection

  Published as AU-B-2003213142

10 November 2005 Application Accepted

  Published as AU-B-2003213142

9 March 2006 Standard Patent Sealed

21 January 2010 Extension of Term of Standard Patents

  Schering Corporation The earliest first regulatory approval date provided by the patentee 27 Aug 2009 For the goods TEMODAL temozolomide Applications Accepted The following application(s) for Extension of Term have been accepted under Section 74. Notice of opposition under Section 75(1) to the undermentioned application(s) for an extension of term may be filed at the Patent Office within the prescribed time.

25 February 2010 Extension of Term of Standard Patents

  Schering Corporation The earliest first regulatory approval date provided by the patentee 27 Aug 2009 For the goods TEMODAL temozolomide Address for service in Australia: Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

15 July 2010 Extension granted

  Schering Corporation The earliest first regulatory approval date provided by the patentee 27 Aug 2009 For the goods TEMODAL temozolomide Extension of Term of patent pursuant to Section 77 expires on 27 Aug 2024

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003213143-Method and apparatus for wet trapping with energy curable flexographic liquid inks

2003213141-ABRASIVE FLOORING MATERIAL AND METHOD OF MAKING SAME